Effects of chronic administration with nilvadipine against immunohistochemical changes related to aging in the mouse hippocampus

Metabolic Brain Disease

Volumn 20, Issue 2, 2005, Pages 141-153

  Himeda, Toshiki ^a   Kanbara, Shiori ^a   Oki, Chie ^a   Kato, Hiroyuki ^b   Araki, Tsutomu ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b INTERNATIONAL UNIVERSITY OF HEALTH AND WELFARE   (Japan)

Author keywords

Aging; Hippocampal CA1 neurons; Mice; Nilvadipine; S100 ; Ubiquitin

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; DIHYDROPYRIDINE DERIVATIVE; NILVADIPINE; PROTEIN S100B; UBIQUITIN;

AGING; ANIMAL EXPERIMENT; ARTICLE; CELL DAMAGE; CELL POPULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LONG TERM CARE; MALE; MOUSE; NERVE CELL; NEUROPROTECTION; NONHUMAN; PERINATAL PERIOD; PROTEIN FUNCTION; STATISTICAL SIGNIFICANCE;

AGING; ANIMALS; CALCIUM CHANNEL BLOCKERS; CELL DEATH; CELL PROLIFERATION; CYTOPROTECTION; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; DRUG ADMINISTRATION SCHEDULE; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MALE; MEMORY DISORDERS; MICE; MICE, INBRED ICR; NERVE DEGENERATION; NERVE GROWTH FACTORS; NEURONS; NEUROPROTECTIVE AGENTS; NIFEDIPINE; OXIDATIVE STRESS; S100 PROTEINS; UBIQUITIN;

EID: 20044375928     PISSN: 08857490     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11011-005-4151-9     Document Type: Article

References (46)

1. Angenstein, F., Buchner, K., and Staak, S. (1999). Age-dependent differences in glutamate-induced phosphorylation systems in rat hippocampal slices. Hippocampus 9:173-185.
2. Araki, T., Kato, H., Kanai, Y., and Kogure, K. (1993). Postischemic changes of intracellular second messengers in the gerbil brain after long-term survival: An autoradiographic study. Neuroscience 53:829-836.
3. Finley, D., Özkaynak, E., and Varshavsky, A. (1987). The yeast polyubiquitin gene is essential for resistance to high temperatures, starvation, and other stresses. Cell 48:1035-1046.
4. Foster, T.C. (1999). Involvement of hippocampal synaptic plasticity in age-related memory decline. Brain Res. Rev. 30:236-249.
5. Foster, T.C., and Norris, C.M. (1997). Age-associated changes in Ca(2+)-dependent processes: Relation to hippocampal synaptic plasticity. Hippocampus 7:602-612.
6. 2+ dysregulation with brain aging. J. Neurosci. 21:4066-4073.
7. Gibson, G.E., and Peterson, C. (1987). Calcium and the aging nervous system. Neurobiol. Aging 8:329-343.
8. Grady, C.L., and Craik, F.I. (2000). Changes in memory processing with age. Curr. Opin. Neurobiol. 10:224-231.
9. Griffin, W.S., Stanley, L.C., Ling, C., White, L., MacLeod, V., Perrot, L.J., White, C.L., III, and Araoz, C. (1989). Brain interleukin 1 and S-100immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 86:7611-7615.
10. Hartmann, H., Velbinger, K., Eckert, A., and Müllar, W.E. (1996). Region-specific downregulation of free intracellular calcium in the aged rat brain. Neurobiol. Aging 17:557-563.
11. Hayashi, T., Tanaka, J., Kamikubo, T., Takada, K., and Matsuda, M. (1993). Increase in ubiquitin conjugates dependent on ischemic damage. Brain Res. 620:171-173.
12. Heizmann, C.W., and Braun, K. (1992). Changes in Ca (2+)-binding proteins in human neurodegenerative disorders. Trends Neurosci. 15:259-264.
13. Hershko, A., and Ciechanover, A. (1998). The ubiquitin system. Annu. Rev. Biochem. 67:425-479.
14. Hersi, A.I., Rowe, W., Gaudreau, P., and Quirion, R. (1995). Dopamine D1 receptor ligands modulate cognitive performance and hippocampal acetylcholine release in memory-impaired aged rats. Neuroscience 69:1067-1074.
15. Karege, F., Lambercy, C., Schwald, M., Steimer, T., and Cisse, M. (2001). Differential changes of cAMP-dependent protein kinase activity and 3H-cAMP binding sites in rat hippocampus during maturation and aging. Neurosci. Lett. 315:89-92.
16. Kato, H., Chen, T., Liu, X.H., Nakata, N., and Kogure, K. (1993). Immunohistochemical localization of ubiquitin in gerbil hippocampus with induced tolerance to ischemia. Brain Res. 619:339-343.
17. Khachaturian, Z.S. (1989). The role of calcium regulation in brain aging: Reexamination of a hypothesis. Aging (Milano) 1:17-34.
18. 2+ antagonists on motor activity and the dopaminergic system in aged mice. Neurobiol. Aging 24:315-319.
19. Kuwaki, T., Satoh, H., Ono, T., Shibayama, F., Yamashita, T., and Nishimura, T. (1989). Nilvadipine attenuates ischemic degradation of gerbil brain cytoskeletal proteins. Stroke 20:78-83.
20. Kuzuhara, S., Mori, H., Izumiyama, N., Yoshimura, M., and Ihara, Y. (1988). Lewy bodies are ubiquitinated. A light and electron microscopic immunocytochemical study. Acta Neuropathol (Berl.) 75:345-353.
21. Matsui, T., Mori, T., Tateishi, N., Kagamiishi, Y., Satoh, S., Katsube, N., Morikawa, E., Morimoto, T., Ikuta, F., and Asano, T. (2002). Astrocytic activation and delayed infarct expansion after permanent local ischemia in rats. Part I. enhanced astrocytic synthesis of S-100β in the periinrarct area precedes delayed infarct expansion. J. Cereb. Blood Flow Metab. 22:711-722.
22. Mattson, M.P. (1992). Calcium as sculptor and destroyer of neural circuitry. Exp. Gerontol. 27:29-49.
23. Migheli, A., Cordera, S., Bendotti, C., Atzori, C., Piva, R., and Schiffer, D. (1999). S-100β protein is upregulated in astrocytes and motor neurons in the spinal cord of patients with amyotrophic lateral sclerosis. Neurosci. Lett. 261:25-28.
24. Mori, H., Kondo, J., and Ihara, Y. (1987). Ubiquitin is a component of paired helical filaments in Alzheimer's disease. Science 235:1641-1644.
25. Moyer, J.R., Jr., Thompson, L.T., Black, J.P., and Disterhoft, J.F. (1992). Nimodipine increases excitability of rabbit CA1 pyramidal neurons in an age- and concentration-dependent manner. J. Neurophysiol. 68:2100-2109.
26. Muramatsu, Y., and Araki, T. (2002). Glial cells as a target for the development of new therapies for treating Parkinson's disease. Drug News Perspect. 15:586-590.
27. Muramatsu, Y., Kurosaki, R., Kato, H., and Araki, T. (2004). Effect of pitavastatin against expression of S100β protein in the gerbil hippocampus after transient cerebral ischemia. Acta Physiol. Scand. 182:95-107.
28. Muramatsu, Y., Kurosaki, R., Watanabe, H., Michimata, M., Matsubara, M., Imai, Y., and Araki, T. (2003). Expression of S-100 protein is related to neuronal damage in MPTP-treated mice. Glia 42:307-313.
29. Okada, M., Sakaguchi, T., and Kawasaki, K. (1995). Correlation between anti-ubiquitin immunoreactivity and region-specific neuronal death in N-methyl-D-aspartate-treated rat hippocampal organotypic cultures. Neurosci. Res. 22:359-366.
30. Palis, D., Quadros, A., Humphrey, J., Patel, N., Crescentini, R., Crawford, F., and Mullan, M. (2004). Nilvadipine antagonizes both Aβ vasoactivity in isolated arteries, and the reduced cerebral blood flow in APPsw transgenic mice. Brain Res. 999:53-61.
31. Poe, G.R., Teed, R.G., Insel, N., White, R., McNaughton, B.L., and Barnes, C.A. (2000). Partial hippocampal inactivation: Effects on spatial memory performance in aged and young rats. Behav. Neurosci. 114:940-949.
32. Rapp, P.R., and Amaral, D.G. (1992). Individual differences in the cognitive and neurobiological consequences of normal aging. Trends Neurosci. 15:340-345.
33. Reeves, R.H., Yao, J., Crowley, M.R., Buck, S., Zhang, X., Yarowsky, P., Gearhart, J.D., and Hilt, D.C. (1994). Astrocytosis and axonal proliferation in the hippocampus of S100β transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 91:5359-5363.
34. Regner, A., Kaufman, M., Friedman, G., and Chemale, I. (2001). Increased serum S100β protein concentrations following severe head injury in humans: A biochemical marker of brain death? Neuroreport 12:691-694.
35. Schäfer, B.W., and Heizmann, C.W. (1996). The S100 family of EF-hand calcium-binding proteins: Functions and pathology. Trends Biochem. Sci. 21:134-140.
36. Selinfreund, R.H., Barger, S.W., Pledger, W.J., and Van Eldik, L.J. (1991). Neurotrophic protein S100β stimulates glial cell proliferation. Proc. Natl. Acad. Sci. U.S.A. 88:3554-3558.
37. Sharps, M.J., and Gollin, E.S. (1987). Memory for object locations in young and elderly adults. J. Gerontol. 42:336-341.
38. Sheng, J.G., Mrak, R.E., and Griffin, W.S. (1997). Glial-neuronal interactions in Alzheimer disease: Progressive association of IL-1α+ microglia and S100β+ astrocytes with neurofibrillary tangle stages. J. Neuropathol. Exp. Neurol. 56:285-290.
39. Siesjö, B.K., Bengtsson, F., Grampp, W., and Theander, S. (1989). Calcium, excitotoxins and neuronal death in the brain. Ann. N.Y. Acad. Sci. 568:234-251.
40. Takakura, S., Furuichi, Y., Yamamoto, T., Ogawa, T., Satoh, H., and Mori, J. (1994). Effect of nilvadipine on the development of neurological deficits in stroke-pone spontaneously hypertensive rats. Stroke 25:677-683.
41. Takakura, S., Sogabe, K., Satoh, H., Mori, J., Fujiwara, T., Totsuka, Z., Tokuma, Y., and Kohsaka, M. (1992). Nilvadipine as a neuroprotective calcium entry blocker in a rat model of global cerebral ischemia. A comparative study with nicardipine hydrochloride. Neurosci. Lett. 141:199-202.
42. Tateishi, N., Mori, T., Kagamiishi, Y., Satoh, S., Katsube, N., Morikawa, E., Morimoto, T., Matsui, T., and Asano, T. (2002). Astrocytic activation and delayed infarct expansion after permanent focal ischemia in rats. Part II. suppression of astrocytic activation by a novel agent (R)-(-)-2-propyloctanoic acid (ONO-2506) leads to mitigation of delayed infarct expansion and early improvement of neurologic deficits. J. Cereb. Blood Flow Metab. 22:723-734.
43. Tokuma, Y., Fujiwara, T., and Noguchi, H. (1987). Absorption, distribution and excretion of nilvadipine, a new dihydropyridine calcium antagonist, in rats and dogs. Xenobiotica 17:1341-1349.
44. Van Eldik, L.J., Ehrenfried, B., and Jensen, R.A. (1984). Production and characterization of monoclonal antibodies with specificity for S100β polypeptide of brain S100 functions. Proc. Natl. Acad. Sci. U.S.A. 81:6034-6038.
45. Whitaker-Azmitia, P.M., Wingate, M., Borella, A., Gerlai, R., Roder, J., and Azmitia, E.C. (1997). Transgenic mice overexpressing the neurotrophic factor S-100β show neuronal cytoskeletal and behavioral signs of altered aging processes: Implications for Alzheimer's disease and Down's syndrome. Brain Res. 776:51-60.
46. Zimmer, D.B., Cornwall, E.H., Landar, A., and Song, W. (1995). The S100 protein family: History, function, and expression. Brain Res. Bull. 37:417-429.